Neogen Chemicals: Financial Results and Project Revisions

Neogen Chemicals' board has approved the company's audited financial results for the fiscal year ending March 31, 2026. The company reported a consolidated net profit of ₹34.83 crore. Standalone revenue from operations for the fiscal year reached ₹871.31 crore.

A final dividend of Re. 1 per equity share was recommended, subject to shareholder approval.

Project costs for Neogen Ionics Limited's Dahej (Phase 1) and Pakhajan (Phase 2) projects were revised upwards to a total of ₹1,795 crore. The project timelines have been extended, with Dahej Phase 1 expected by February 2027 and Pakhajan Phase 2 by March 2027.

The financial results received an unmodified audit opinion. The company is pursuing recovery for a fire incident on March 5, 2025. Management considers the net insurance claim receivable fully recoverable.

Investor Impact and Outlook

The results offer a clear financial overview of Neogen Chemicals for fiscal year 2026. The recommended dividend provides a direct return to shareholders.

The significant revision in project costs and extended timelines for Neogen Ionics underline the company's substantial capital expenditure plans and associated financial commitments. The update on insurance claim recovery from the 2025 fire incident clarifies the event's financial impact.

Background on Projects and Incidents

Neogen Ionics Limited is a subsidiary focused on developing specialized chemical projects. A fire occurred at Neogen Chemicals' manufacturing facility on March 5, 2025, leading to insurance claims.

Key Adjustments and Next Steps

Shareholders will vote on the recommended final dividend of Re. 1 per equity share. Total capital expenditure for Neogen Ionics' projects now stands at ₹1,795 crore. The Dahej and Pakhajan projects are now scheduled for completion in early 2027. The company has a recorded insurance receivable for the 2025 fire event, which it considers fully recoverable.

Potential Risks

Potential for further cost increases or delays in the large-scale Dahej and Pakhajan expansion projects. Risks associated with executing and managing these significant capacity expansions at Neogen Ionics.

Industry Landscape

Neogen Chemicals operates in the competitive specialty chemicals sector. Competitors such as Aarti Industries Ltd. and SRF Ltd. are also undertaking capacity expansions and product diversification. Navin Fluorine International Ltd. is another competitor, specializing in fluorine chemistry.

Key Financial Figures

• Standalone Revenue (FY26): ₹871.31 crore
• Consolidated Net Profit (FY26): ₹34.83 crore
• Outstanding Borrowings (Mar 31, 2026): ₹321.52 crore
• Net Insurance Claim Receivable (Standalone, Mar 31, 2026): ₹188.96 crore

Looking Ahead

• Shareholder approval for the final dividend.
• Confirmation of the dividend record date and the date for the 37th Annual General Meeting (AGM).
• Progress reports on construction and commissioning of the Dahej and Pakhajan projects.
• Management commentary explaining the project cost revisions and timeline adjustments.
• Updates on the final settlement and recovery of the insurance claim from the 2025 fire incident.